Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
Open | $1.81 |
Close | $1.85 |
Volume / Avg. | 8.20M / 9.98M |
Day Range | 1.80 - 1.95 |
52 Wk Range | 1.16 - 13.70 |
Market Cap | $503.86M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 23.88% |
Days to Cover | 6.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pacific Biosciences (NASDAQ:PACB) through any online brokerage.
Other companies in Pacific Biosciences’s space includes: Harvard Bioscience (NASDAQ:HBIO), 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS) and Lifecore Biomedical (NASDAQ:LFCR).
There is no analysis for Pacific Biosciences.
Pacific Biosciences has a consensus price target of $7.75.
The stock price for Pacific Biosciences (NASDAQ: PACB) is $1.85 last updated July 23, 2024 at 7:56 PM EDT.
There are no upcoming dividends for Pacific Biosciences.
Pacific Biosciences’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Pacific Biosciences.
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.